Prediction: Nvidia Stock Is a Buy Before May 20

Nvidia expects Q1 fiscal 2027 revenue of $78 billion at the midpoint, implying about 77% year-over-year growth, and investors will focus on Q2 guidance for signs of a China rebound. The company is set to resume H200 chip sales in China and still holds an estimated 55% share there, while management has projected $1 trillion in sales from Vera Rubin and Blackwell through 2027. The article is broadly bullish on Nvidia’s AI demand outlook, though shares have lagged amid concerns about an AI bubble and geopolitical rotation away from tech.

Analysis

The market is still treating NVDA like a mature mega-cap when the setup is closer to a two-stage re-rating: near-term earnings durability plus a second-leg acceleration if China reopens meaningfully and management confirms demand depth into the next architecture cycle. The key second-order effect is that a China normalization does not just add incremental revenue; it also improves utilization across the supply chain, which can tighten lead times, reinforce pricing power, and pull forward orders from hyperscalers trying to lock capacity before the next product transition. That is a stronger catalyst than a simple beat, because it raises the probability that forward estimates move up faster than the stock’s current multiple reflects.

The bigger market implication is not just NVDA upside, but relative underperformance in names levered to a spending pause or localization thesis. If Nvidia proves it can reaccelerate China share while keeping global demand intact, then semi capex budgets likely stay elevated longer, pressuring competitors that depend on a slower digestion phase. Intel remains a weaker second-order beneficiary at best; a faster AI infrastructure cycle helps the broad semiconductor tape, but it does not solve its architectural and ecosystem disadvantages, so any sympathy bid there is likely tactical rather than fundamental.

The main risk is timing mismatch: the stock may need one or two quarters of confirmation before the market is willing to pay for the longer-dated Vera Rubin/Blackwell optionality. That creates a tactical window where consensus remains underpositioned, but failure to guide Q2 above the implied run-rate would quickly expose the trade as crowded-on-the-good-news. The contrarian takeaway is that the market may be underestimating how much deferred China demand can snap back once restrictions loosen, but overestimating how quickly that will translate into linearly better stock performance without a visible guide-up.

For a 3-12 month horizon, the setup is asymmetric: downside is capped by already-lofty but normalized expectations, while upside comes from compounding revisions plus multiple expansion if AI spend proves non-cyclical through the next product cycle. The cleaner expression is to own NVDA into the print with defined risk, rather than chase the stock after confirmation, because the stock’s biggest moves are still driven by guidance deltas, not the headline quarter itself.

Key Decisions for Investors

• Long NVDA into the next earnings print; favor a 1-3 month horizon. Best risk/reward is via call spreads to capture a guide-up without paying full vol, with thesis failure if Q2 guidance merely matches the current implied run-rate.
• Pair trade: long NVDA / short INTC over the next 3-6 months. If AI capex remains elevated and China reopens, the market should reward the category leader while treating Intel as a lagging beneficiary with limited direct leverage.
• Add on any post-earnings dip only if management raises or reaffirms the second-half demand curve. That would indicate revisions are still ahead; if the stock sells off despite a guide-up, it likely reflects positioning, creating a better entry than pre-print.
• For more convex exposure, buy NVDA upside calls 1-2 quarters out and finance them by selling out-of-the-money calls above the likely post-print implied move. This expresses a view that consensus is underpricing multi-quarter demand durability.
• Avoid chasing semiconductor beta indiscriminately; prefer NVDA over SMH-type baskets because the catalyst is company-specific guidance revision, not just sector sentiment. If the print disappoints on China timing, basket exposure should be cut first.